Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alexza posts Q2 earnings, stock closes down 8%
Bizjournals.com
Tuesday, August 9, 2011 - 10:03am
tags:
Alexza, earnings
Medicis not discussing Valeant rumors, sees 2Q income slide
Bizjournals.com
Monday, August 8, 2011 - 11:02pm
tags:
M&A, Medicis, earnings, Valeant Pharmaceuticals
Is MannKind Running Out of Time?
Motley Fool
Monday, August 8, 2011 - 10:47pm
tags:
diabetes, Afrezza, inhaled insulin, MannKind
Pfizer Taps UCSD for $50M Drug Discovery Program
Motley Fool
Monday, August 8, 2011 - 10:45pm
tags:
Pfizer, drug discovery
Valeant-Medicis: Investors Still Love Deal Makers
WSJ Online
Monday, August 8, 2011 - 2:04pm
tags:
M&A, Medicis, Valeant Pharmaceuticals
Will Bristol-Myers Squibb Earn or Burn?
Motley Fool
Monday, August 8, 2011 - 1:22pm
tags:
Bristol-Myers Squibb
Genentech pitches Avastin compromise to FDA
Fierce Pharma
Monday, August 8, 2011 - 12:39pm
tags:
FDA, breast cancer, Avastin, Genentech
Botox gets EU green light as bladder treatment
Fierce Pharma
Monday, August 8, 2011 - 12:37pm
tags:
Botox, Europe, Allergan, urinary incontinence
Bayer eyes Pfizer's animal health business -magazine
Reuters
Monday, August 8, 2011 - 12:34pm
tags:
Pfizer, Bayer, animal health, M&A
Wave of lawsuits follow warnings that top-selling diabetes drug may raise bladder cancer risk
Yahoo/AP
Monday, August 8, 2011 - 12:30pm
tags:
bladder cancer, diabetes, Takeda, Actos
Pozen wins court battle over migraine drug
Bizjournals.com
Monday, August 8, 2011 - 12:27pm
tags:
Par Pharmaceutical, Pozen, migraines, Treximet, generics
Cytokinetics sinks 18% in early trading
Marketwatch
Monday, August 8, 2011 - 11:50am
tags:
Cytokinetics
Teva Sued by GlaxoSmithKline, Pfizer Venture Over HIV Drug
Bloomberg
Monday, August 8, 2011 - 11:24am
tags:
GSK, Pfizer, Teva Pharmaceuticals, HIV, Epzicom
Insmed, Inc. Earnings Cheat Sheet: Widening Losses Push Company Below Estimates
Yahoo/AP
Monday, August 8, 2011 - 11:23am
tags:
earnings, Insmed
Qiagen: FDA Submissions May Make This Bottom Bouncer More Appealing
Seeking Alpha
Monday, August 8, 2011 - 11:22am
tags:
Qiagen, FDA, Erbitux, cancer
Merck gets subpoena tied to marketing of 3 drugs
Yahoo/AP
Monday, August 8, 2011 - 11:21am
tags:
Merck, Temodar, PegIntron, Intron A, hepatitis C, Schering Plough
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus
Motley Fool
Monday, August 8, 2011 - 9:18am
tags:
Dendreon, biotech, Provenge, prostate cancer
Cardiome Reports Second Quarter Results
Yahoo
Monday, August 8, 2011 - 9:17am
tags:
earnings, Cardiome
Teva Receives FDA Acceptance of Its New Drug Application for BDP Nasal HFA for the Treatment of Allergic Rhinitis
Yahoo
Monday, August 8, 2011 - 9:14am
tags:
Teva Pharmaceuticals, FDA, BDP Nasal HFA, allergic rhinitis
Valeant Pharma Beats, Ups View
Yahoo/Zacks.com
Monday, August 8, 2011 - 9:11am
tags:
earnings, Valeant Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.